News und Analysen

The 6.7% dividend yield on offer from Pfizer (NYSE: PFE) is both a sign of opportunity and risk. A lot will happen over the next five years that will determine if that dividend is sustainable. But

Nektar Therapeutics (NASDAQ: NKTR) is a small-cap biotech that has garnered plenty of attention this year. The company's shares have soared, increasing by 285% since January. Yet, some analysts

CCM Investment Advisers disclosed a new position in Advanced Micro Devices (NASDAQ:AMD) in its October 10, 2025 Securities and Exchange Commission filing. The estimated $11.13 million purchase

On Oct. 9, 2025, BDF-GESTION disclosed it sold 39,327 shares of Advanced Micro Devices (NASDAQ:AMD) in Q3 2025, an estimated $6.35 million transaction.

BDF-Gestion disclosed in a U.S. Securities and

If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.

Dividend Champions fit the bill

Like it or not, and whether we trust driverless vehicles yet or not, they're on the way, and the future is coming faster than many investors realize. The driverless vehicle market has enormous

There's no denying Nvidia (NASDAQ: NVDA) has earned its place as the world's biggest publicly traded company. Its technology is the heart and soul of most of the planet's artificial intelligence

Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big

UnitedHealth (NYSE: UNH) shares are up significantly since I upgraded the stock to a buy rating.

*Stock prices used were the afternoon prices of Oct. 6, 2025. The video was published on Oct. 8

There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better

As President Donald Trump's escalating tariff policies threaten to raise costs across global supply chains, one pharmaceutical giant is taking steps to protect its bottom line. On Sept. 30, Pfizer

The leading pipeline drug being developed by Cidara Therapeutics (NASDAQ: CDTX) got a real boost from a regulator on Thursday, and the biotech's share price moved accordingly. Cidara's stock closed

Shares in Viking Therapeutics (NASDAQ: VKTX) were up more than 16% in the week to Thursday at 1 pm. The move comes after the announcement of another acquisition of a small-cap biopharmaceutical

In today's video, I discuss recent updates impacting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and CoreWeave (NASDAQ: CRWV). To learn more, check out the short video, consider

Wilsey Asset Management disclosed the purchase of Pfizer shares valued at an estimated $2.9 million during the third quarter, according to an SEC filing released Wednesday.

According to a filing

Carolina Wealth Advisors, LLC disclosed in an Oct. 7, 2025, U.S. Securities and Exchange Commission filing that it sold 38,267 AbbVie shares for the quarter ended Sept. 30, 2025, an estimated $7.79

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of more than $760 billion. It has been soaring in recent years due to the success of its highly

Do you want to invest in some underrated artificial intelligence (AI) stocks? The ones that are listed here may be intriguing options because while they might seem expensive at first glance, they

Advanced Micro Devices Inc (NASDAQ: AMD) closed at $235.56, up 11.37%. Trading volume reached 154 million shares, roughly 3 times its three-month average of 58 million. The stock hit a new 52-week

On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to avoid President Donald Trump's tariffs for three years in exchange for slashing the prices